baber/WOPTO huggingface dataset:
Patent CY-1120226-T1 (CY)
Title: Μεθοδος για την προωθηση της αγγειογενεσης, της αγγειωσης ή της αποκαταστασης των αγγειων ή για την αναστολη της αγγειογενεσης ογκων
Inventor: DIMMELER STEFANIE
IPC: C12N15/113
Filed: 2017-12-06
Abstract: Η εφεύρεση αφορά μια μέθοδο για την επίδραση της έκφρασης του miR-92 αποτελείται από τα ακόλουθα βήματα: (α) παροχή ενός κυττάρου, και (β1) Μείωση της έκφρασης του miR-92 στο κύτταρο για την προώθηση της αγγειογένεσης, της αγγείωσης ή/και της αποκατάστασης των αγγείων μέσω της εισαγωγής ενός αντίστροφου μορίου έναντι του miR-92 στο κύτταρο, ή (β2) Αύξηση της έκφρασης του miR-92 στο κύτταρο για την αναστολή της αγγειογένεσης όγκου μέσω της εισαγωγής μιας δομής στο κύτταρο, όπου η δομή περιλαμβάνει μια εκφράσιμη αλληλουχία miR-92. Περαιτέρω, η εφεύρεση αφορά μια φαρμακευτική σύνθεση, που περιλαμβάνει ένα μέσο για τη μείωση της δραστηριότητας του miR-92 ή την έκφραση σε ένα κύτταρο σε μορφή ενός αντίστροφου μορίου έναντι του miR-92, ή ένα μέσο για την αύξηση της έκφρασης του miR-92 σε ένα κύτταρο με τη μορφή μιας δομής για την έκφραση του miR-92.
Patent CY-1120185-T1 (CY)
Title: Υποκατεστημενα πυριδινικα παραγωγα χρησιμα ως αναστολεις c-fms κινασης
Inventor: CHEN JIE
IPC: C07D405/14
Filed: 2018-04-27
Abstract: Η παρούσα εφεύρεση αναφέρεται σε υποκατεστημένα πυριδινικά παράγωγα, φαρμακευτικές συνθέσεις που περιέχουν τα εν λόγω παράγωγα και στη χρήση των εν λόγω παραγώγων στη θεραπεία διαταραχών στις οποίες διαμεσολαβεί c-fms κινάση. Η παρούσα εφεύρεση αναφέρεται περαιτέρω σε μέθοδο για την παρασκευή των εν λόγω υποκατεστημένων πυριδινικών παραγώγων.
Patent CY-1122490-T1 (CY)
Title: Αντισωματα κατα του ανθρωπινου cd38
Inventor: WEERS MICHEL DE
IPC: C07K16/28
Filed: 2020-01-16
Abstract: Αποκαλύπτονται απομονωμένα μονοκλωνικά αντισώματα τα οποία δεσμεύονται στο ανθρώπινο CD38 και σχετικές βασιζόμενες σε αντισώματα συνθέσεις και μόρια. Επίσης αποκαλύπτονται φαρμακευτικές συνθέσεις που περιλαμβάνουν τα αντισώματα και θεραπευτικές και διαγνωστικές μέθοδοι για τη χρήση των αντισωμάτων.
Patent CY-1123351-T1 (CY)
Title: Χρηση του κανναβιδιολικου οξεος στη θεραπεια της επιληψιας
Inventor: STOTT COLIN
IPC: A61K31/05
Filed: 2020-09-17
Abstract: Η παρούσα εφεύρεση αναφέρεται στη χρήση μιας θεραπευτικά αποτελεσματικής ποσότητας κανναβιδιολικού οξέος (CBDA) στη θεραπεία της επιληψίας. Σε μια υλοποίηση, το CBDA χρησιμοποιείται στη θεραπεία των γενικευμένων κρίσεων, κατά προτίμηση στη θεραπεία των τονικών-κλονικών κρίσεων. Κατά προτίμηση, το CBDA που χρησιμοποιείται έχει τη μορφή μιας βοτανικής φαρμακευτικής ουσίας στην οποία η περιεκτικότητα του CBDA είναι μεγαλύτερη από 60%, και ακόμη προτιμότερα, είναι ένα πολύ καθαρισμένο εκχύλισμα κάνναβης έτσι ώστε το CBDA να υπάρχει σε ποσοστό μεγαλύτερο από 95%, σε ποσοστό 96% και 97% έως, κατά μέγιστη προτίμηση, σε ποσοστό που ξεπερνά το 98% του συνολικού εκχυλίσματος (w/w). Τα υπόλοιπα συστατικά του εκχυλίσματος χαρακτηρίζονται. Συγκεκριμένα, η τετραϋδροκανναβινόλη (THC) ή το τετραϋδροκανναβιδιολικό οξύ (THCA) έχουν αφαιρεθεί ουσιαστικά. Εναλλακτικά, το CBDA μπορεί να παρασκευαστεί συνθετικά.
Patent CY-1123502-T1 (CY)
Title: Συνθεση ρητινης για χρηση σε χυτευση
Inventor: MATSUMURA KENICHI
IPC: C08K5/098
Filed: 2020-10-23
Abstract: H παρούσα εφεύρεση παρέχει μια σύνθεση ρητίνης για χύτευση που επιτρέπει την παραγωγή ενός χυτευμένου σώματος που έχει εξαιρετική θερμική σταθερότητα όπως επίσης και υψηλή ευκαμψία και αντοχή, χωρίς τη χρήση βαρέων μετάλλων όπως ο μόλυβδος και ο κασσίτερος, και επίσης παρέχει ένα χυτευμένο σώμα που λαμβάνεται χρησιμοποιώντας τη σύνθεση ρητίνης για χύτευση. Η παρούσα εφεύρεση παρέχει μια σύνθεση ρητίνης για χύτευση, που περιλαμβάνει ένα χλωριωμένο πολυβινυλοχλωρίδιο κι έναν θερμικό σταθεροποιητή, το οποίο χλωριωμένο πολυβινυλοχλωρίδιο έχει τις δομικές μονάδες (a) ως (c) που αντιπροσωπεύεται από τους τύπους (a) ως (c) που φαίνονται παρακάτω: -CCl2- (a), -CHCl- (b), -CH2- (c), όπου το ποσοστό της δομικής μονάδας (a) είναι 17,5 mol% ή παρακάτω, το ποσοστό της δομικής μονάδας (b) είναι 46,0 mol% ή παραπάνω, και το ποσοστό της δομικής μονάδας (c) είναι 37,0 mol% ή παρακάτω, σε σχέση με το συνολικό αριθμό γραμμομορίων των δομικών μονάδων (a), (b) και (c), το χλωριωμένο πολυβινυλοχλωρίδιο έχει περιεκτικότητα σε χλώριο 63% κατά μάζα ή παραπάνω και κάτω από 72 % κατά μάζα, ο θερμικός σταθεροποιητής περιέχει ένα άλκυλο καρβοξυλικό ασβέστιο και μια ένωση ψευδαργύρου, και η σύνθεση ρητίνης για χύτευση έχει απώλεια μάζας κατά τη θέρμανση στους 230°C κάτω από 2% κατά μάζα.
Patent HR-P20120058-T1 (HR)
Title: Methods and compounds for preparing cc-1065 analogs
Inventor: GANGWAR SANJEEV
IPC: C07D403/12
Filed: 2012-01-19
Abstract: A method of forming a CBI CC-1065 analog utilizes NH2 as a starting material, where R3 is H or alkyl and R6 is H, substituted or unsubstituted lower alkyl, cyano, or alkoxy. Intermediates (I) are used and are claimed.
Patent SI-1214076-T1 (SI)
Title: Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
Inventor: HEIL WOLFGANG
IPC: A61P15/00
Filed: 2000-08-31
Abstract: The present invention relates to a multiple-phase pharmaceutical preparation consisting of a number of separately packaged and individually removable daily dosage units placed in a packaging unit and intended for oral administration for a period of at least 21 consecutive days, wherein said daily dosage unit comprises a natural estrogen, such as estradiol in an amount of from 0.5 mg to 4 mg, and 2 to 4 mg of drospirenone, and wherein at least 70% of said drospirenone is dissolved from said dosage unit within 30 minutes, as determined by USP XXIII Paddle Method II using water at 37°C as the dissolution media and 50 rpm as the stirring rate.
Patent SI-1341526-T1 (SI)
Title: Pharmaceutical compositions for the oral delivery of calcitonin
Inventor: AULT JOSEPH M
IPC: A61K47/16
Filed: 2001-12-05
Abstract: Solid pharmaceutical compositions suitable for the oral delivery of pharmacologically active agents, e.g. peptides, comprising a therapeutically-effective amount of a pharmacologically active agent; a crospovidone or povidone; and a delivery agent for said pharmacologically active agent are disclosed. The compositions provide excellent oral bioavailability of pharmacologically active agents, particularly calcitonin.
Patent SI-1501931-T1 (SI)
Title: Chimeric snrna molecules carrying antisense sequences against the splice junctions of the dystrophin gene and their therapeutic applications
Inventor: BOZZONI I
IPC: A61K38/00
Filed: 2003-05-06
Abstract: A gene is described that encodes for a snRNA modified such that it contains an antisense sequence complementary to at least one of the two splice junctions at 5' and/or 3' of one of the exons encoding for a protein of therapeutic interest, whose sequence should be skipped during the splicing process that converts the pre-mRNA to the mature mRNA. The gene is particularly advantageous which it contain segments complementary to both splice junctions. If introduced into appropriate vectors, the gene is useful in gene therapy, particularly in the treatment of Duchenne Muscular Dystrophies. dystrophic diseases.
Patent SI-1885637-T1 (SI)
Title: Apparatus for winding up at least two material webs
Inventor: TAUBER ADOLF
IPC: B65H19/22
Filed: 2006-05-30
Abstract: An arrangement for winding up at least two material webs, in particular film webs, having at least two receiving devices, for the rotatable mounting of at least one winding core each. The receiving devices are transferable between a winding position for winding up at least one material web on the winding core, and a removal or loading position, respectively, for removing at least one winding core which has finished being wound up, or for feeding at least one empty winding core. At least two winding cores are coaxially arranged in the receiving device for simultaneously winding up the material webs on separate winding cores, the winding cores each being rotatably mounted in two bearing sites adjacent to the respective winding core. The receiving device has at least three carrying arms, one winding core each being mounted between two carrying arms.
Patent DE-3486216-T2 (DE)
Inventor: BARR PHILIP J
IPC: C12N15/16
Filed: 1984-04-13
Granted: 1994-02-17
Abstract: Prodn. of human insulin-like growth factor (IGF) comprises growing host cells contg. a structural gene which comprises a functional DNA construct of the gene encoding IGF joined in proper reading frame with secretory leader and processing signal sequences recognised by the host, and isolating secreted human IGF. The structural gene is downstream from and under transcriptional regulatory control of a transcriptional initiation region in a vector compatible with the host. The host is pref. a yeast. A DNA construct comprising a coding sequence for human IGF under transcriptional regulation of regulatory signals utilised by yeast is new. Also claimed is a construct contg. the IGF gene for expression in a cultured cellular host. Nucleotide sequences are defined with corresp. aminoacid sequence.
Patent DE-3650564-T2 (DE)
Inventor: CHMURNY ALAN BRUCE
IPC: C07K5/075
Filed: 1986-10-21
Granted: 1997-01-16
Abstract: Dipeptides of formula (I) are new: In (I) B=H or Q; Q=amino acid protecting gp; V=H or 1-4C alkyl; asterisks indicate the natural amino acid configuration; one of X and Y=H and the other is HET (i.e. an opt substd. hetero-atomic gps., releasable from the C by redn) or both are HET, or XCY is a HET ring or non-cyclic HET gp. Also new are the phenylalanine cpd of formula (III) and their salts; provides that X-C-Y is not H-C-OH. More specifically Y=H and X=OR1, SR1, OCOR1, OCOOR, OCONHR1, OCSSR, or NHR1; or both are OR1 or SR1, or together complete S(CH2)nS, O(CH2)nO, TsNHN=, =N.NH.CO.NH2, =N.NH.COR1 or =NOH; R1=H or R; R=1-4C opt. substd. alkyl or alkenyl, or opt substd. aryl; n=1-4; Ts=tosyl.
Patent DE-3685971-T2 (DE)
Inventor: KURAMOTO MASAHIKO
IPC: C08F10/02
Filed: 1986-02-22
Granted: 1992-12-24
Abstract: A process for producing ethylene-based polymers by polymerizing ethylene or ethylene and other  alpha -olefins by the use of a catalyst consisting essentially of (A) a transition metal compound component and (B) an organometallic compound component, said component (A) being a reaction product of (i) a specified chromium compound with (ii) a specified metal compound, and said component (B) being a halogen-containing alkylaluminium compound. According to the present invention, ethylene-based polymers can be efficiently produced.
Patent DE-3686421-T2 (DE)
Inventor: EASTMOND C
IPC: H04B1/10
Filed: 1986-11-03
Granted: 1993-01-28
Abstract: An improved FM communication system is disclosed in which noise bursts and pops in the audio output of the receiver, due to weak and Rayleigh-faded signals, are minimized by selectively attenuating the audio signal in the receiver. The amount and rate of attenuation for the receiver noise reduction circuits is determined by a control signal derived form either the average discriminator noise at frequencies above 3 kHz, or from a received RF signal strength indicator, or a combination of both. The audio output is attenuated during weak signals or Rayleigh fades only when the attenuation control signal increases above a predetermined signal-to-noise ratio threshold. Also described are further improvements to noise attenuation devices used in combination with the receiver noise reduction circuits to enhance audio quality in particular applications, e.g., FM repeater systems which may incorporate multiple transmitters in a simulcast configuration.
Patent DE-3780896-T2 (DE)
Inventor: NEWKIRK MARC S
IPC: C04B35/65
Filed: 1987-09-03
Granted: 1992-12-24
Abstract: A method for producing a self-supporting ceramic composite structure comprising a ceramic matrix embedding a filler (38) includes oxidizing a parent metal to form a polycrystalline material comprising the oxidation reaction product of the parent metal with an oxidant and, optionally, one or more metallic constituents, and the filler (38) embedded by the matrix. The method includes heating the parent metal to provide a first source (36) of molten parent metal and a reservoir (34) of molten parent metal and contacting the first source (36) of molten parent metal with a permeable bedding of filler (38). The first source (36) of molten parent metal is reacted with the oxidant to form the oxidation reaction product and is replenished from the reservoir (34) as the reacting continues for a time sufficient to grow the oxidation reaction product to a desired boundary and thereby embed at least a portion of the bedding of filler (38) within the oxidation reaction product to form the ceramic composite structure. The bedding of filler (38) may have any suitable shape, including that of a hollow body, the interior of which is contacted by the first source (36) of molten parent metal to grow the oxidation reaction product through the shaped, hollow body of filler.
Patent DE-3852103-T2 (DE)
Inventor: HEEFNER DONALD
IPC: C12N15/04
Filed: 1988-06-02
Granted: 1995-03-23
Abstract: Strains of yeast of the species Candida famata are disclosed which can produce 10 grams of riboflavin per liter in 6 days, and in particular, strains identified by ATCC Accession Nos. 20849 and 20850. Riboflavin yields of more than 20 grams per liter in 200 hours have been achieved. Strains of the present invention have increased sensitivity to iron inhibition of flavinogenesis and have enhanced riboflavin production per cell at increased iron concentrations in the fermentation medium.
Patent TR-199802319-T2 (TR)
Inventor: MUNN ERNEST ALFERD
IPC: G07D7/02
Filed: 1997-06-24
Abstract: Apparatus for monitoring a document (11) to determine the presence of an electrically conductive element (1a, 1b) on or in the document (1) as the document is fed along a path (2). The apparatus includes at least two detection systems (40, 41) laterally spaced apart with respect to the direction of movement of the document along the path. The detection systems include antennae (6, 7, 8, 9, 10) for generating and detecting signals which are modified in the presence of an electrically conductive element (1a, 1b). A control system (20) is connected to the detection systems (40, 41) for monitoring signals from the detection system. Furthermore, a document detector (42, 43) for each detection system (40, 41) is positioned upstream of and on the same side of the centre line of the document feed path (6) of the respective detection system (40, 41). Each document detector (43) is connected to the control system (20), with the control system (20) being responsive to signals from the document detectors (42, 43) to monitor the corresponding detection system (40, 41) in a predetermined manner. This takes account of a skew fed document (1) to indicate the presence of an electrically conductive element (1a, 1b) if the monitored signals satisfy predetermined conditions.
Patent TR-199901378-T2 (TR)
Inventor: HOSTETTLER R NE
IPC: B02C4/02
Filed: 1997-09-24
Abstract: Bulus, özellikle tahil ürünleri üretimi için ögütme degirmenlerinde kullanilan merdane gövdesi ile ilgilidir. Bulus bir merdane çifti üzerine yerlestirilen merdane gövdeleri ve dozaj tertibatindan olusan besleme sistemlerine dayalidir ve özellikle sihhilik ve ulasilabilirligi iyilestirmeye yöneliktir. Bu, bir dönüs noktasi (14) etrafinda dönebilen bir çerçeve (13) içine bir alt-takim olarak dozaj tertibati, dagitim medanesi ve merdane gövdeleri (9, 10) yerlestirilmesi ile gerçeklestirilir.
Patent DE-60000288-T2 (DE)
Inventor: NG KINGMAN
IPC: A61K9/08
Filed: 2000-01-26
Granted: 2003-01-16
Abstract: The present invention provides formulations and methods for preparing formulations containing an aqueous solution at a pH of greater than about 7.9. The aqueous solution includes an isotonicity agent, a phenolic derivative, zinc ions, and an acylated human insulin analog. More particularly, the invention relates to formulations having a pH of greater than about 7.9 that include a monoacylated human insulin analog such as an acylated des(B30) human insulin analog or an analog that comprises a native or modified human insulin A chain optionally modified at position A21, and a modified native human insulin B chain optionally modified at position B3 and modified at position B28, or at both positions B28 and B29, and that contains a lysine residue at either position B28 or B29 acylated with a fatty acid residue. The invention also provides a method for treating a patient suffering from hyperglycemia using the pharmaceutical formulations of the invention.
Patent DE-60009377-T2 (DE)
Inventor: MIH PHILIPPE
IPC: E05C9/18
Filed: 2000-01-27
Granted: 2005-05-04
Abstract: The bolt or rod (2) attached to the lock box (1) consists of a flat strap sliding on the bottom of a shallow U-shaped channel (26). A guide block (8) holds a closure strip (3) which spans the gap between the sides of the U-section and holds the flat strap in the U-section. The whole assembly has a very small thickness.
Patent DE-60009947-T2 (DE)
Inventor: CONTA RENATO
IPC: B41J2/16
Filed: 2000-11-14
Granted: 2005-04-07
Abstract: An actuating assembly ( 50 ) for ink jet printheads consists of a silicon die ( 61 ), which comprises a groove ( 45 ) and a lamina ( 64 ), and of a structure ( 75 ) produced monolithically in the same production process. The actuating assembly ( 50 ) comprises a microhydraulics ( 63 ), the latter in turn comprising a plurality of channels ( 67 ) and chambers ( 57 ), made inside the structure ( 75 ) by means of a sacrificial metallic layer ( 54 ). A conducting layer ( 26 ) forms a single interconnected equipotential network used as the electrode during the processes of electrochemical etch stopping on the groove ( 45 ), of electrodeposition of the sacrificial layer ( 54 ) and of the latter's subsequent removal.
Patent DE-60013268-T2 (DE)
Inventor: KELLAR EWEN JAMES CRAWFORD
IPC: A61B8/08
Filed: 2000-04-17
Granted: 2005-09-08
Abstract: Ultrasound detectable instrument including a bubble generator having two elements which, upon contact with each other in the presence of a fluid, react with each other to produce gas bubbles which may be detected by sonic imaging equipment. The two elements comprise first and second radially displaced layers of the elements within a fluid permeable carrier material.
Patent DE-60017421-T2 (DE)
Inventor: MARTIKAINEN MIKA
IPC: H01M4/62
Filed: 2000-06-28
Granted: 2005-12-22
Abstract: The invention relates to a method for preparing a cobaltous hydroxide with a high density and a large particle size or an alloy hydroxide of cobalt and some other metal, in which a complexing agent and hydroxide ion is added to an aqueous cobalt brine or an aqueous brine of cobalt and some other metal under alkaline conditions in order to form a metal hydroxide. In this method, the complexing agent is selected so as to form an ammonium complex with the metal ion. The molar ratio of complexing agent to metal is about 0.5-3, and the pH is regulated in the range 10-13.
Patent DE-60019945-T2 (DE)
Inventor: CAIZZA J
IPC: A61M5/315
Filed: 2000-01-04
Granted: 2006-02-16
Abstract: Retracting needle syringe (20) includes barrel (22) having chamber (24), open proximal end (25) and open distal end (26). The plunger has an elongated cavity (34) in its distal end and a sealing cover element (35). Needle assembly (40) includes needle cannula (41) having inner hub with distal end connected so that the lumen is in fluid communication with the chamber. A flange on the inner hub is connected to an outer hub and a spring is contained between the hubs. A release element is movably connected to the flange and has a sharp proximal end projecting into the chamber. Distal motion of the plunger causes the sharp proximal end to cut through the cover element and the release element to dissociate an outer portion of the flange from an inner portion of the flange allowing the spring to expand and move the needle cannula into the cavity.
Patent DE-60026605-T2 (DE)
Inventor: TASKINEN KIMMO
IPC: H04L27/20
Filed: 2000-12-14
Granted: 2006-08-10
Abstract: Amplitudes of signals produced by a digital modulator can be clipped so that instead of processing the output vector of the digital modulator or it's component vectors, processing is applied to the base band I and Q signals prior to modulation. The I- and Q signals are applied to an input of a clipping circuit. Predetermined limit values are also applied to another input of the clipping circuit. The clipping circuit rotates on the I-Q vector towards the limit vector. At the same time the limit vector is rotated towards the I-Q vector. Rotations are performed by using Cordic algorithm. After rotations have been completed, the rotated I-Q vector is aligned with the original limit vector, and the rotated limit is aligned with the original I-Q vector. Then the length of the rotated I-Q vector will be compared with the original limit vector. If the rotated I-Q vector is shorter than the limit vector, then the original I-Q signals are output signals from the clipping circuit. But if the rotated original I-Q vector is longer than the limit vector, then the original I-Q signals will be rejected and substituted by the coordinate values of the rotated limit vector.
Patent DE-60028442-T2 (DE)
Inventor: SIMON MARC RAYMOND
IPC: G08C17/02
Filed: 2000-04-10
Granted: 2007-01-11
Abstract: A device (21,22,23,24) on a motor vehicle (20) is controlled by selecting a function for the device to perform. The selection is conveyed to a control circuit (27) which wirelessly transmits a message using the Digital Enhanced Cordless Telecommunications protocol, wherein the message identifies the device (21,22,23,24) and function. A controller (25) receives the message and recovers the identification of the device (21,22,23,24) and the function and then responds by activating the device to perform that function. <IMAGE>
Patent DE-60030016-T2 (DE)
Inventor: NAHEIRI TARIK
IPC: B01D53/053
Filed: 2000-02-04
Granted: 2007-02-22
Abstract: A PSA process comprises (a) introducing a pressurized feed gas mixture (1) into a feed end of an adsorber vessel (17) containing a solid adsorbent which preferentially adsorbs the more strongly adsorbable component(s) of the mixture, withdrawing from a product end of the adsorber vessel an adsorber effluent gas enriched in the less strongly adsorbable component(s), and introducing at least a portion of the adsorber effluent gas into a gas storage tank (39); (b) terminating introduction of the pressurized feed gas into the adsorber vessel (17) and depressurizing the adsorber vessel (17) by evacuating gas from the feed end thereof; (c) continuing to evacuate gas from said feed end while simultaneously introducing stored adsorber effluent gas from the gas storage tank (39) into the product end of the adsorber vessel (17) until the pressure in the adsorber vessel (17) reaches a minimum adsorber pressure; (d) terminating the evacuating of gas from said feed end of the adsorber vessel and repressurizing the adsorber vessel (17) from the minimum adsorber pressure to an intermediate pressure by introducing pressurized feed gas into said feed end while continuing to introduce stored adsorber effluent gas from the gas storage tank (39) into said product end; (e) further repressurizing the adsorber vessel (17) to the feed pressure by continuing to introduce pressurized feed gas into said feed end; and (f) repeating steps (a) through (e) in a cyclic manner. . The process preferably is carried out in a simple system which utilizes a single two-way four-port valve (7) for controlling gas flow between the adsorber vessel (17) and a blower (11) which is used for both the introduction of feed gas into and the evacuation of gas from the adsorber vessel (17). The control of gas flow in either direction between the adsorber vessel (17) and a product gas storage tank (39) preferably is accomplished by two check valves (23,43) installed in parallel between, and responsive to respective differential pressures between, the adsorber vessel (17) and the tank (39). <IMAGE>